Although vitamin E can block mutagenesis and cell transformation in vi
tro and can reduce the number of chemically induced colonic adenomas i
n mice, previous clinical trials have found no protective effect of vi
tamin E supplements against colorectal adenomas, and epidemiological s
tudies have found only weak protective effects of dietary or plasma al
pha-tocopherol against colorectal cancer, We previously examined first
diagnosis of colorectal adenomas in a sigmoidoscopy screening populat
ion and failed to find a protective effect of dietary vitamin E. Becau
se measurements of dietary intake may not be a good proxy of vitamin E
status, we assayed plasma alpha- and gamma-tocopherol concentration f
or 332 subjects with colorectal adenomas and 363 control subjects from
this previous sigmoidoscopy-based study, Increasing alpha-tocopherol
and decreasing gamma-tocopherol levels were associated with decreased
occurence of large (greater than or equal to 1 cm) but not of small (<
1 cm) adenomas; however, after adjustment for potential confounding va
riables, these trends were not statistically significant, A strong tre
nd (P = 0.02) was observed by using the alpha-tocopherol:gamma-tocophe
rol ratio, which may be a more sensitive indicator of alpha-tocopherol
intake, Subjects in the highest versus lowest quintile of alpha-tocop
herol:gamma-tocopherol ratio had an odds ratio of 0.36 (95% confidence
interval, 0.14-0.95) for large adenomas, The finding that a high alph
a-tocopherol:gamma-tocopherol ratio is associated with decreased occur
rence of large, but not of small, colorectal adenomas is consistent wi
th previous findings that alpha-tocopherol may be protective against c
olon cancer, A high plasma alpha-toeopherol:gamma-tocopherol ratio may
be a better predictor of decreased cancer risk than high plasma alpha
-tocopherol alone.